• Defsec’s MD&A for the three and nine months ended June 30, 2026 flagged continued losses and negative operating cash flow typical of an early-stage business.
• Management attributed performance to limited revenue scale across most products and services, with operations funded mainly through financing activities.
• Continuation as a going concern was tied to securing additional sales orders, executing timely commercial launches, and raising additional debt or equity financing.
• Management highlighted Adjusted EBITDA as a core performance lens, excluding share-based compensation, FX moves, derivative fair-value changes, and nonrecurring items.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Defsec Technologies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001062993-26-004229), on August 12, 2026, and is solely responsible for the information contained therein.